Company intelligence / Profile preview

Lilypad Health

Atlanta, Georgia, United Statescreate-x.gatech.edu ↗

Ownership: Private
Employees: ~9
Development stage: Preclinical

Overview

Lilypad Health has developed a non-invasive, at-home menstrual blood collection device that enables users to screen for gynecological diseases, thyroid function, diabetes risk markers, fertility hormones, HPV, and potentially other health indicators. The company has demonstrated that their method provides detection rates comparable to standard blood tests. They are currently working on patenting the technology and preparing for clinical trials in collaboration with Emory University. The product is not yet commercially available.

Therapeutic areas: Women's Health
Modalities: DeviceNon-pharmacological therapy (diagnostic)
Industry: Molecular Diagnostics

Partnerships

Emory University (clinical trial collaboration)

Beyond the preview

Go deeper on Lilypad Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lilypad Health.

Explore the full profile